US stocks swing | Impressive weight loss drug data triggers a surge, Viking Therapeutics (VKTX.US) jumps over 30%

According to Zhitong Finance APP, on Tuesday, Viking Therapeutics (VKTX.US) opened high and continued rising, surging over 30% as of press time. In terms of news, this biotechnology company announced that its experimental obesity drug VK2735 helped patients maintain most of their weight loss even when the dosing frequency was reduced from once a week to once every two weeks. This result is expected to further strengthen VK2735’s competitive position in the rapidly expanding weight loss drug market. VK2735 is considered a potential rival to blockbuster weight loss drugs such as Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy.